about
The pathology of unusual subtypes of prostate cancerThe update of prostatic ductal adenocarcinomaPrimary Lymphoepithelioma-Like Carcinoma of the Prostate Gland: A Review of the LiteratureGenetically engineered mouse models of prostate cancerA dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cellsGene expression profiles of ductal versus acinar adenocarcinoma of the prostate.Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model.Molecular genetics of prostate cancer: new prospects for old challengesClinical features and outcomes of 25 patients with primary adenosquamous cell carcinoma of the prostate.Male reproductive cancers and infertility: a mutual relationship.Prostate cancer stem cells: The case for model systemsPC3 is a cell line characteristic of prostatic small cell carcinoma.Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens.Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway.Prostate carcinoma II: prognostic factors in prostate needle biopsies.Solitary Spinal Epidural Metastasis from Prostatic Small Cell Carcinoma.Basal cell carcinoma of the prostate: report of a case and review of the published reports.Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma.Prostate cancer: the need for biomarkers and new therapeutic targets.Premalignant and malignant prostate lesions: pathologic review.Current perspectives on Gleason grading of prostate cancer.Sarcomatoid carcinoma of prostate involving the whole lower urinary tract and rectum.Ductal variant of prostate adenocarcinoma harbor Xenotropic murine leukemia virus related virus (XMRV) infection: a novel finding in subtype of prostate cancer.Prostatic ductal adenocarcinoma: An aggressive variant that is underdiagnosed and undersampled on transrectal ultrasound (TRUS)-guided needle biopsy.Pseudolumen size and perimeter in prostate cancer: correlation with patient outcome.A biomimetic approach to hormone resistant prostate cancer cell isolation using inactivated Sendai virus (HVJ-E).An aggressive signet ring cell carcinoma of the prostate in a Japanese man.Sarcomatoid carcinoma of the prostate: a case reportDigital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome.Sarcomatoid carcinoma of the prostate.Squamous cell carcinoma of the prostate following treatment with an LHRH-agonist: a rare case of transformation of adenocarcinoma of the prostate.Metastatic Mucinous Adenocarcinoma of the Prostate with PSA Value of 8.6 ng/mL at 5-Year-Followup after Prostatectomy, Radiotherapy, and Androgen Deprivation.Mixed adenocarcinoma, sarcomatoid carcinoma and adenosquamous carcinoma of the prostate: A case report.An 82-year-old Caucasian man with a ductal prostate adenocarcinoma with unusual cystoscopic appearance: a case report.Sarcomatoid carcinoma of the prostate: ductal adenocarcinoma and stromal sarcoma-like appearance: a rare association.Ductal and Acinar Adenocarcinoma of Prostate: Morphological and Immunohistochemical Characterization.Prostatic carcinosarcoma with lung metastases.Ductal carcinoma of the prostate shows a different immunophenotype from high grade acinar cancer.PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade.High-Grade Primary Spindle Cell Sarcoma of the Prostate: A Case Report and Review of the Literature.
P2860
Q26752906-310D8240-28A7-4513-AD48-2D3092C885EAQ26752939-D946FF93-A711-460F-B87D-A6B6F0077A3EQ26765494-115770E7-8BA6-457E-A7FA-CF842B3C43A4Q27026768-DB551A4C-05F0-48FD-82E7-BF6A2C88B22DQ28573536-1E0A6E61-315A-43DB-8328-4D9BE2CAC2E9Q33487123-4B8B3121-35C3-40AA-B72E-88012B6DB5CFQ34078067-998D7F93-DF4A-4A6D-8A02-92A769B246E5Q34127462-9EDE865B-F2AA-45A2-8707-CB4C6E22F867Q34364965-826AFD97-1A13-40D7-8A8C-4C1376AF3701Q35585478-A712B2D9-FAFB-4B28-B4F5-1AD0865FCD17Q35890704-096498D3-3422-4267-8DD9-118999A1ACA6Q36185201-9E70E93D-1182-493A-BF94-DAA6FE75C401Q36194953-5983F885-448B-4BEA-B994-5A0EFE9B17B3Q36206304-506F6F20-9FEC-4FB3-AD16-F7B9E85A4F7DQ36392186-E781E498-5CC0-404E-8BDD-455FD647E364Q37054074-FDBA59CD-983D-4BF6-9972-21C7E213A5EAQ37167685-5FF2C0C4-43CC-4B8F-AF70-195C8D3C918FQ37383449-49B0E6A9-C1A0-48FD-9A75-BD481534AFCDQ37476043-80D97B11-8EDC-4A0E-AE54-86B71446FE3AQ37791390-DE9D99AB-E8B1-4751-B517-7FF8EAC3D914Q37855669-182DC5A0-D350-4466-AE7D-944EC9AC5522Q38169144-0438B5E6-CAAC-4994-B370-F80583764A29Q38371963-CFD212D0-88B3-445C-98B7-A93183EFD2F3Q38668632-AA291891-BBB3-46D7-A088-B078A354879EQ38808255-EBD4B43F-4E52-4DBD-874B-3ED914AF26DFQ38820595-EF426379-9E5B-4C79-9374-973EFE3CB84CQ39256898-4C476CB0-3497-4790-859F-09F48DED8A83Q39554972-5EB52D5B-B71D-4DBA-A91D-634F401697D1Q39987660-A22858A1-0E3E-47EB-AB9D-0720119679A8Q40186828-C5A0A1C0-316D-4B48-9ADA-1F6820216FFFQ41452958-850929B7-E5B5-4239-A765-6B5B4902A82BQ41959344-407BEA99-2421-42C9-9217-39681CC0C61CQ42067376-DEB9B3DE-5B9B-4FD5-8558-DA9A564ED38EQ42093197-8D21D1FE-B706-44C0-AD1B-688255398679Q42157849-8426E85B-97B0-435A-8509-ECA1662547ACQ42591821-352955A8-9A80-4536-B8A3-D1E40D567A5BQ42874776-3F762328-BC3F-4F5F-A4FF-AB5D09E63BE0Q44747186-9B9A94F2-049B-45EC-9F43-4050A5544E97Q45359397-7EADEB5B-CC9C-44C7-8875-5477EB87C3BEQ45529609-D9A032B1-F753-4445-BD55-DF6209021619
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Unusual subtypes of prostate cancer.
@ast
Unusual subtypes of prostate cancer.
@en
type
label
Unusual subtypes of prostate cancer.
@ast
Unusual subtypes of prostate cancer.
@en
prefLabel
Unusual subtypes of prostate cancer.
@ast
Unusual subtypes of prostate cancer.
@en
P2860
P1433
P1476
Unusual subtypes of prostate cancer.
@en
P2093
David J Grignon
P2860
P2888
P304
P356
10.1038/MODPATHOL.3800052
P577
2004-03-01T00:00:00Z